DOCCHECK AG (AJ91.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:AJ91 - DE000A1A6WE6 - Common Stock
11 EUR
-0.1 (-0.9%)
Overall AJ91 gets a fundamental rating of 7 out of 10. We evaluated AJ91 against 11 industry peers in the Health Care Technology industry. AJ91 scores excellent points on both the profitability and health parts. This is a solid base for a good stock. AJ91 has a decent growth rate and is not valued too expensively. AJ91 also has an excellent dividend rating. These ratings could make AJ91 a good candidate for dividend investing.
1. Profitability
1.1 Basic Checks
In the past year AJ91 was profitable.
AJ91 had a positive operating cash flow in the past year.
Each year in the past 5 years AJ91 has been profitable.
Each year in the past 5 years AJ91 had a positive operating cash flow.
1.2 Ratios
AJ91 has a better Return On Assets (9.09%) than 81.82% of its industry peers.
AJ91 has a Return On Equity of 13.18%. This is amongst the best in the industry. AJ91 outperforms 81.82% of its industry peers.
AJ91 has a better Return On Invested Capital (8.86%) than 63.64% of its industry peers.
AJ91 had an Average Return On Invested Capital over the past 3 years of 9.31%. This is in line with the industry average of 9.28%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.09% | ||
| ROE | 13.18% | ||
| ROIC | 8.86% |
ROA(3y)7.87%
ROA(5y)12.82%
ROE(3y)11.84%
ROE(5y)19.17%
ROIC(3y)9.31%
ROIC(5y)15.17%
1.3 Margins
The Profit Margin of AJ91 (9.82%) is better than 72.73% of its industry peers.
AJ91's Profit Margin has been stable in the last couple of years.
The Operating Margin of AJ91 (12.33%) is better than 72.73% of its industry peers.
In the last couple of years the Operating Margin of AJ91 has declined.
AJ91 has a Gross Margin of 79.18%. This is in the better half of the industry: AJ91 outperforms 72.73% of its industry peers.
AJ91's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.33% | ||
| PM (TTM) | 9.82% | ||
| GM | 79.18% |
OM growth 3Y-13.6%
OM growth 5Y-2.73%
PM growth 3Y-9.54%
PM growth 5Y0.26%
GM growth 3Y11.03%
GM growth 5Y-0.26%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AJ91 is creating some value.
Compared to 1 year ago, AJ91 has about the same amount of shares outstanding.
AJ91 has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AJ91 has been reduced compared to a year ago.
2.2 Solvency
AJ91 has an Altman-Z score of 4.18. This indicates that AJ91 is financially healthy and has little risk of bankruptcy at the moment.
AJ91 has a better Altman-Z score (4.18) than 81.82% of its industry peers.
AJ91 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.18 |
ROIC/WACC1.29
WACC6.88%
2.3 Liquidity
AJ91 has a Current Ratio of 2.74. This indicates that AJ91 is financially healthy and has no problem in meeting its short term obligations.
AJ91 has a better Current ratio (2.74) than 81.82% of its industry peers.
A Quick Ratio of 2.50 indicates that AJ91 has no problem at all paying its short term obligations.
The Quick ratio of AJ91 (2.50) is better than 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.74 | ||
| Quick Ratio | 2.5 |
3. Growth
3.1 Past
AJ91 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 133.18%, which is quite impressive.
The Earnings Per Share has been growing by 10.57% on average over the past years. This is quite good.
The Revenue has been growing slightly by 0.69% in the past year.
The Revenue has been growing by 10.68% on average over the past years. This is quite good.
EPS 1Y (TTM)133.18%
EPS 3Y-22.65%
EPS 5Y10.57%
EPS Q2Q%501.79%
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-14.46%
Revenue growth 5Y10.68%
Sales Q2Q%7.91%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.58, the valuation of AJ91 can be described as reasonable.
Based on the Price/Earnings ratio, AJ91 is valued cheaper than 81.82% of the companies in the same industry.
AJ91 is valuated cheaply when we compare the Price/Earnings ratio to 26.38, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.58 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AJ91 is valued cheaper than 90.91% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AJ91 is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.57 | ||
| EV/EBITDA | 3.22 |
4.3 Compensation for Growth
AJ91 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
AJ91 has a Yearly Dividend Yield of 6.76%, which is a nice return.
Compared to an average industry Dividend Yield of 2.30, AJ91 pays a better dividend. On top of this AJ91 pays more dividend than 90.91% of the companies listed in the same industry.
AJ91's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.76% |
5.2 History
The dividend of AJ91 has a limited annual growth rate of 4.52%.
Dividend Growth(5Y)4.52%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
48.02% of the earnings are spent on dividend by AJ91. This is a bit on the high side, but may be sustainable.
AJ91's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP48.02%
EPS Next 2YN/A
EPS Next 3YN/A
FRA:AJ91 (12/19/2025, 7:00:00 PM)
11
-0.1 (-0.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners8.71%
Inst Owner ChangeN/A
Ins Owners71.92%
Ins Owner ChangeN/A
Market Cap55.77M
Revenue(TTM)53.79M
Net Income(TTM)5.28M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.76% |
Yearly Dividend0.5
Dividend Growth(5Y)4.52%
DP48.02%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.58 | ||
| Fwd PE | N/A | ||
| P/S | 1.04 | ||
| P/FCF | 8.57 | ||
| P/OCF | 7.3 | ||
| P/B | 1.39 | ||
| P/tB | 1.4 | ||
| EV/EBITDA | 3.22 |
EPS(TTM)1.04
EY9.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.28
FCFY11.67%
OCF(TTM)1.51
OCFY13.7%
SpS10.61
BVpS7.91
TBVpS7.87
PEG (NY)N/A
PEG (5Y)1
Graham Number13.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.09% | ||
| ROE | 13.18% | ||
| ROCE | 14.96% | ||
| ROIC | 8.86% | ||
| ROICexc | 17.58% | ||
| ROICexgc | 17.72% | ||
| OM | 12.33% | ||
| PM (TTM) | 9.82% | ||
| GM | 79.18% | ||
| FCFM | 12.1% |
ROA(3y)7.87%
ROA(5y)12.82%
ROE(3y)11.84%
ROE(5y)19.17%
ROIC(3y)9.31%
ROIC(5y)15.17%
ROICexc(3y)16.17%
ROICexc(5y)32.75%
ROICexgc(3y)16.36%
ROICexgc(5y)34.31%
ROCE(3y)15.72%
ROCE(5y)25.61%
ROICexgc growth 3Y-26.82%
ROICexgc growth 5Y-2.82%
ROICexc growth 3Y-26.26%
ROICexc growth 5Y-1.57%
OM growth 3Y-13.6%
OM growth 5Y-2.73%
PM growth 3Y-9.54%
PM growth 5Y0.26%
GM growth 3Y11.03%
GM growth 5Y-0.26%
F-Score6
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 45.88% | ||
| Cap/Sales | 2.11% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.94% | ||
| Profit Quality | 123.15% | ||
| Current Ratio | 2.74 | ||
| Quick Ratio | 2.5 | ||
| Altman-Z | 4.18 |
F-Score6
WACC6.88%
ROIC/WACC1.29
Cap/Depr(3y)102.11%
Cap/Depr(5y)131.26%
Cap/Sales(3y)5.41%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)133.18%
EPS 3Y-22.65%
EPS 5Y10.57%
EPS Q2Q%501.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-14.46%
Revenue growth 5Y10.68%
Sales Q2Q%7.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y86.96%
EBIT growth 3Y-26.09%
EBIT growth 5Y7.66%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.74%
FCF growth 3Y-1.99%
FCF growth 5Y54.46%
OCF growth 1Y1.69%
OCF growth 3Y-11.25%
OCF growth 5Y33.53%
DOCCHECK AG / AJ91.DE FAQ
Can you provide the ChartMill fundamental rating for DOCCHECK AG?
ChartMill assigns a fundamental rating of 7 / 10 to AJ91.DE.
Can you provide the valuation status for DOCCHECK AG?
ChartMill assigns a valuation rating of 5 / 10 to DOCCHECK AG (AJ91.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for DOCCHECK AG?
DOCCHECK AG (AJ91.DE) has a profitability rating of 7 / 10.
What is the valuation of DOCCHECK AG based on its PE and PB ratios?
The Price/Earnings (PE) ratio for DOCCHECK AG (AJ91.DE) is 10.58 and the Price/Book (PB) ratio is 1.39.
Can you provide the dividend sustainability for AJ91 stock?
The dividend rating of DOCCHECK AG (AJ91.DE) is 8 / 10 and the dividend payout ratio is 48.02%.